|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenues: | ||||
| Life insurance premiums and other fees | ||||
| Interest and investment income | ||||
| Owned distribution revenues | ||||
| Recognized gains and (losses), net | ||||
| Total revenues | ||||
| Benefits and expenses: | ||||
| Benefits and other changes in policy reserves | ||||
| Market risk benefit losses (gains) | ||||
| Depreciation and amortization | ||||
| Personnel costs | ||||
| Other operating expenses | ||||
| Interest expense | ||||
| Total benefits and expenses | ||||
| Earnings (loss) before income taxes | ||||
| Earnings from discontinued operations, net of tax | ||||
| Income tax expense | ||||
| Net earnings (loss) | ||||
| Less: Non-controlling interests | ||||
| Less: Preferred stock dividend | ||||
| Net earnings (loss) attributable to F&G common shareholders | ||||
| Earnings per share | ||||
| Basic | ||||
| Net earnings from discontinuing operations (in usd per share) | ||||
| Net earnings (loss) per share attributable to F&G common shareholders, basic (in usd per share) | ||||
| Diluted | ||||
| Net earnings from discontinuing operations (in usd per share) | ||||
| Net earnings (loss) per share attributable to F&G common shareholders, diluted (in usd per share) | ||||
| Weighted average shares outstanding F&G common stock, basic basis (in shares) | ||||
| Weighted average shares outstanding F&G common stock, diluted basis (in shares) | ||||
Loading...